Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board.

MemorialCare Deploys Abridge’s GenAI Clinical Documentation Across Enterprise

What You Should Know: – MemorialCare, a healthcare system in Southern California, announced today a partnership with Abridge, a company pioneering the use of generative

April 17, 2024

How to Achieve Health Equity in Decentralized Clinical Trials

Katrina Rice, Chief Delivery Officer, Biometrics Services at eClinical Solutions Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI)

June 29, 2023

The surprising role of RNA in immune interactions

In a groundbreaking exploration of cell surface biology, Ryan Flynn has uncovered a surprising role for RNA outside the confines of the cell. Flynn’s research,

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.